COMBRIAX is the world's first flu plus COVID combination vaccine to receive a positive CHMP opinion recommending ...
Novavax Inc. NVAX shares are up on Thursday following the company’s announcement of its fourth-quarter and full-year 2025 ...
NEXSPIKE is the third Moderna vaccine authorized in the European Union, strengthening the Company's respiratory vaccine portfolio in Europe ...
BioNTech SE BNTX has filed a patent infringement lawsuit against Moderna Inc. MRNA, alleging that Moderna's next-generation COVID-19 vaccine, mNEXSPIKE, relies on proprietary technology developed and ...
The audit examined record-keeping between 2021 and 2024 at the facility, conduct that is also part of an active police ...
“This is happening right now and I need you to understand it.” This is how Matt Shumer, HyperWrite CEO and serial investor, frames the moment of current AI development in a recent essay that’s gone ...
The U.S. FDA’s expectations that its new default position of basing marketing authorization of novel drugs on one adequate, well-controlled trial may be overstated. In explaining the policy in a ...
Jack Dorsey, CEO of fintech group Block, has admitted that the company overhired during the COVID-19 pandemic, leading to workplace layoffs ...
Bronson Reed discusses his friendship with Dominik Mysterio.
The Worker Adjustment and Retraining Notification Act (WARN) issued a notice on when layoffs will begin at International ...
Tri Pointe Homes, Inc. (the "Company") (NYSE: TPH) today announced results for the fourth quarter ended December 31, 2025 and full year 2025.
CDI‑988 is the first oral antiviral drug candidate being developed for prevention and treatment of norovirus infectionsCompany to present Phase 1 ...